- DARTISLA ODT is available as a 1.7 mg orally disintegrating tablet and is indicated for adults to reduce symptoms of a peptic ulcer as an adjunct to treatment of peptic ulcer - First and only orally ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Edenbridge Pharmaceuticals, the U.S. subsidiary of Dexcel Pharma, today announced that Douglas S. Boothe has been named Chief Executive Officer, effective January 1, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback